n/a
Abstract Title:

Allicin Reduces 5-fluorouracil-resistance in Gastric Cancer Cells through Modulating MDR1, DKK1, and WNT5A Expression.

Abstract Source:

Drug Res (Stuttg). 2021 Jul 14. Epub 2021 Jul 14. PMID: 34261152

Abstract Author(s):

Parya Khakbaz, Reza Panahizadeh, Mohammad Amin Vatankhah, Nowruz Najafzadeh

Article Affiliation:

Parya Khakbaz

Abstract:

BACKGROUND & OBJECTIVE: 5-fluorouracil (5-FU) is approved for the treatment of gastric carcinoma (GC), but chemo-resistance limits the application of it for GC. Thus, the combination of 5-FU with adjuvants such as allicin may overcome multidrug resistance (MDR).

METHODS: The anticancer effects of allicin, 5-FU, and allicin/5-FU on the 5-FU resistant MKN-45 cells were evaluated by MTT assay and DAPi staining. The expression of the P-glycoprotein (P-gp) and CD44 protein were determined using immunocytochemistry. We also quantified mRNA expression levels of(), andin the GC cells.

RESULTS: Here, we found that the combination of allicin with 5-FU significantly increased apoptosis compared to 5-FU alone (<0.05). We showed that,andmRNA expression levels were down-regulated in the allicin- and allicin/5-FU-treated cells. Indeed, the combination of allicin and 5-FU significantly decreased the expression of the P-gp and CD44 proteins (<0.05).

CONCLUSION: Our findings indicate that the combination of allicin with 5-FU could reverse multidrug resistance in the GC cells by reducing the expression of,, P-gp, and CD44 levels.

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.